A2LA announces first clinical laboratory in U.S. accredited to new version of ISO 15189 as part of platinum choice program
The American Association for Laboratory Accreditation (A2LA) has announced that it has accredited the first clinical laboratory in the United States to ISO 15189:2022, the fourth edition and latest version of the standard to be published.
The laboratory, ADL Health, is a participant of A2LA’s Platinum Choice Accreditation Program, a program that combines the requirements of ISO 15189 and CLIA into one assessment.
Headquartered in San Antonio, TX, ADL Health is a molecular diagnostics group that develops and commercializes genetic products and services for reproductive health, precision medicine, and infectious diseases. Their scope of accreditation includes microbiological and chemical testing, including virology, bacteriology, mycology, parasitology, toxicology, and routine chemistry.
For clinical laboratories ready to apply for accreditation to ISO 15189:2022, contact A2LA to begin the process.
